in

A Shared Compass for Patients, Clinicians, and Regulators

Source link : https://newshealth.biz/health-news/a-shared-compass-for-patients-clinicians-and-regulators/

MILAN — The landscape of hematologic malignancies is shifting rapidly, in part due to the evolving significance of measurable (formerly “minimal”) residual disease (MRD). Once confined to the realm of research, MRD is emerging as a critical tool for clinical and regulatory decision-making. In conditions such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), […]

The post A Shared Compass for Patients, Clinicians, and Regulators first appeared on News Health.

—-

Author : News Health

Publish date : 2025-06-14 16:39:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Premiership to Rebrand as the Exciting New ‘Prem’ Starting Next Season

Even Donald Trump Begins to Question the Absurdity of Stephen Miller’s Deportation Targets